Dorsey Brian
Officer at SPRY; SVP, Technical Operations at Somaxon Pharmaceuticals, Inc.
- Sold, on record
- $2.7M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Nov 13, 2025
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- SPRYARS Pharmaceuticals, Inc.Officer
- Somaxon Pharmaceuticals, Inc.SVP, Technical Operations
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Somaxon Pharmaceuticals, Inc.173,180 shares
- SPRY141,828 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice SPRYNoticeAug 13, 2024 2024
Filed to sell 30,000 shares ($390k)
Dorsey Brian, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SPRYRoutineAug 13, 2024 same day
Sold 30,000 shares at $13.00 ($390k)
Dorsey Brian, Chief Operating Officer
10b5-1 planSold 83.3% of holdings ($468k position)6,024 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice SPRYNoticeAug 20, 2024 +7 days
Filed to sell 50,000 shares ($750k)
Dorsey Brian, Officer
10b5-1 planFiling
- 4 Form 4 sale SPRYRoutineAug 20, 2024 same day
Sold 50,000 shares at $15.00 ($750k)
Dorsey Brian, Chief Operating Officer
10b5-1 planSold 89.2% of holdings ($840k position)6,024 shares leftFollows a Form 144Filing
- 5 Form 144 notice SPRYNoticeDec 11, 2024 +113 days
Filed to sell 61,200 shares ($815k)
Dorsey Brian, Officer
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale SPRYRoutineDec 12, 2024 +1 day
Sold 40,000 shares at $12.35 ($494k)
Dorsey Brian, Chief Operating Officer
10b5-1 planSold 86.9% of holdings ($568k position)6,024 shares leftFirst sale on recordFollows a Form 144Filing
- 7 Form 144 notice SPRYNoticeNov 13, 2025 +336 days
Filed to sell 21,828 shares ($190k)
Dorsey Brian, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 sale SPRYUnusualNov 13, 2025 same day
Sold 21,828 shares at $8.71 ($190k)
Dorsey Brian, Chief Operating Officer
No 10b5-1 planSold 66.9% of holdings ($284k position)10,789 shares left0.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Nov 14, 2025 | SPRY | Chief Operating Officer | Form 4 sale | 21,828 | $190k | 66.9% | Unusual | SEC |
| Nov 13, 2025 | Nov 13, 2025 | SPRY | Officer | Form 144 notice | 21,828 | $190k | Notice | SEC | |
| Dec 12, 2024 | Dec 13, 2024 | SPRY | Chief Operating Officer | Form 4 sale | 40,000 | $494k | 86.9% | Routine | SEC |
| Dec 11, 2024 | Dec 11, 2024 | SPRY | Officer | Form 144 notice | 61,200 | $815k | Notice | SEC | |
| Aug 20, 2024 | Aug 21, 2024 | SPRY | Chief Operating Officer | Form 4 sale | 50,000 | $750k | 89.2% | Routine | SEC |
| Aug 20, 2024 | Aug 20, 2024 | SPRY | Officer | Form 144 notice | 50,000 | $750k | Notice | SEC | |
| Aug 13, 2024 | Aug 15, 2024 | SPRY | Chief Operating Officer | Form 4 sale | 30,000 | $390k | 83.3% | Routine | SEC |
| Aug 13, 2024 | Aug 13, 2024 | SPRY | Officer | Form 144 notice | 30,000 | $390k | Notice | SEC | |
| Jan 3, 2012 | Jan 4, 2012 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 9,000 | $4k | 6.3% | Plan not stated | SEC |
| Dec 1, 2010 | Dec 3, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 8,468 | $23k | 16.3% | Plan not stated | SEC |
| Sep 1, 2010 | Sep 3, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 3,000 | $13k | 5.5% | Plan not stated | SEC |
| Aug 25, 2010 | Aug 27, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 5,000 | $25k | 8.8% | Plan not stated | SEC |
| Aug 10, 2010 | Aug 13, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 3,000 | $12k | 5.5% | Plan not stated | SEC |
| Jul 15, 2010 | Jul 16, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 3,000 | $12k | 5.5% | Plan not stated | SEC |
| Jun 24, 2010 | Jun 25, 2010 | Somaxon Pharmaceuticals, Inc. | SVP, Technical Operations | Form 4 sale | 9,000 | $40k | 100.0% | Unusual | SEC |
| Mar 18, 2010 | Mar 22, 2010 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 70,500 | $472k | 88.2% | Unusual | SEC |
| Mar 1, 2010 | Mar 2, 2010 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 29,000 | $116k | 100.0% | Unusual | SEC |
| Feb 5, 2010 | Feb 9, 2010 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 20,712 | $63k | 100.0% | Unusual | SEC |
| Dec 31, 2009 | Jan 5, 2010 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 5,000 | $5k | 9.1% | Plan not stated | SEC |
| May 1, 2009 | May 4, 2009 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 1,000 | $370 | 5.5% | Plan not stated | SEC |
| May 31, 2007 | Jun 4, 2007 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 1,500 | $23k | 100.0% | Unusual | SEC |
| Apr 27, 2007 | Apr 27, 2007 | Somaxon Pharmaceuticals, Inc. | VP Product Development | Form 4 sale | 5,000 | $78k | 100.0% | Unusual | SEC |